Patent details

EP1604681 Title: Use of botulinum toxin in the treatment of joint pain

Basic Information

Publication number:
EP1604681
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP050066257
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of botulinum toxin in the treatment of joint pain
French Title of Invention:
Utilisation de la toxine botulinique dans le traitement des douleurs articulaires
German Title of Invention:
Verwendung von Botulinum Toxin zur Behandlung von Gelenkschmerzen
SPC Number:

Dates

Filing date:
11/04/2001
Grant date:
08/09/2010
EP Publication Date:
08/09/2010
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
14/12/2005
EP B1 Publication Date:
08/09/2010
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/04/2011
Expiration date:
11/04/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
11/04/2001
 
 

Name:
ALLERGAN INC.
Address:
2525 Dupont Drive, Irvine CA 92612, United States (US)

Inventor

1

Name:
Cui Minglei
Address:
United States (US)

2

Name:
Aoki Kei Roger
Address:
United States (US)

3

Name:
Jenkins Stephen
Address:
United States (US)

Priority

Priority Number:
550371
Priority Date:
14/04/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 38/16;
Filing date Document type Number of pages